World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
28413
World Ranking
1356
National Ranking
697

Medicine

D-Index
85
Citations
28621
World Ranking
14533
National Ranking
7353

Research.com Recognitions

  • 2014 - Fellow, National Academy of Inventors

Overview

Douglas F. Nixon is affiliated with Cornell University in the United States. Their research spans several interconnected fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. This work intersects key subfields such as Molecular Biology, Immunology, Infectious Diseases, Virology, and Plant Science.

The scientist's research interests include HIV Research and Treatment, Chromosomal and Genetic Variations, Immune Cell Function and Interaction, as well as SARS-CoV-2 and COVID-19 Research. They have also contributed to studies in COVID-19 Clinical Research and Genomics and Phylogenetic Studies, with a particular emphasis on Cytomegalovirus and herpesvirus research.

Douglas F. Nixon has been actively involved in publishing research papers across a range of high-impact venues. Their frequent publication sources include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Viruses
  • Journal of Medical Virology
  • JCI Insight

Some of the recent papers authored or co-authored by Nixon are as follows:

  • Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy (2020), Journal of Medical Virology
  • Activation of human endogenous retroviruses and its physiological consequences (2023), Nature Reviews Molecular Cell Biology
  • Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target (2020), Viruses
  • SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements (2021), JCI Insight
  • Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers (2021), Cancer Research

The scientist has collaborated frequently with several researchers, including:

  • Matthew L. Bendall
  • Jez L. Marston
  • Nicholas Dopkins
  • Rodrigo R. R. Duarte
  • Timothy R. Powell

In recognition of their contributions, Douglas F. Nixon was named a Fellow of the National Academy of Inventors in 2014.

Best Publications

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

    G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar

  • Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

    R E Phillips;S Rowland-Jones;D F Nixon;F M Gotch

  • HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

    Victor Appay;Douglas F. Nixon;Sean M. Donahoe;Geraldine M.A. Gillespie

  • Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

    Jeff E. Mold;Jakob Michaëlsson;Trevor D. Burt;Marcus O. Muench

  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth

  • Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

    Sandra Lopez-Vergès;Jeffrey M. Milush;Brian S. Schwartz;Marcelo J. Pando

  • CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

    Sandra Lopez-Vergès;Jeffrey M. Milush;Suchitra Pandey;Vanessa A. York

  • Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens

    Einar M. Aandahl;Jakob Michaëlsson;Walter J. Moretto;Frederick M. Hecht

  • HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

    Douglas F. Nixon;Alain R. M. Townsend;John G. Elvin;Charles R. Rizza

  • Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

    M V Dhodapkar;R M Steinman;M Sapp;H Desai

  • An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

    Nina F. Rose;Preston A. Marx;Preston A. Marx;Amara Luckay;Douglas F. Nixon

  • Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

    Lishomwa C. Ndhlovu;Sandra Lopez-Vergès;Jason D. Barbour;R. Brad Jones

  • HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

    S L Rowland-Jones;D F Nixon;M C Aldhous;F Gotch

  • Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    G S Ogg;X Jin;S Bonhoeffer;P Moss

  • Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

    Brinda Emu;Elizabeth Sinclair;David Favre;Walter J. Moretto

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • Regulation of T cell responses in the developing human fetus.

    Jakob Michaëlsson;Jeff E. Mold;Joseph M. McCune;Douglas F. Nixon

  • Tregs control the development of symptomatic West Nile virus infection in humans and mice

    Marion C. Lanteri;Katie M. O’Brien;Whitney E. Purtha;Mark J. Cameron

  • A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

    Marie Larsson;Xia Jin;Bharat Ramratnam;Graham S. Ogg

  • The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

    Felipe Garcia;Montserrat Plana;Gabriel M. Ortiz;Sebastian Bonhoeffer

  • Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development

    Edwin Leeansyah;Liyen Loh;Liyen Loh;Douglas F. Nixon;Johan K. Sandberg

  • Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

    M Larsson;D Messmer;S Somersan;J F Fonteneau

  • Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells

    Annika C. Karlsson;Jeffrey N. Martin;Sophie R. Younger;Barry M. Bredt

  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

    Sebastian Bonhoeffer;Michal Rembiszewski;Gabriel M. Ortiz;Douglas F. Nixon

Frequent Co-Authors

Esper G. Kallas
Esper G. Kallas Universidade de São Paulo
Frederick Hecht
Frederick Hecht University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Mario A. Ostrowski
Mario A. Ostrowski University of Toronto
Johan K. Sandberg
Johan K. Sandberg Karolinska University Hospital
Lishomwa C. Ndhlovu
Lishomwa C. Ndhlovu Cornell University
Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Andrew Wiznia
Andrew Wiznia Albert Einstein College of Medicine
Jakob Michaëlsson
Jakob Michaëlsson Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge while pursuing a career in healthcare, online degree programs can offer flexible and specialized pathways. Many students start with an online ADN programs for non nurses, which provide foundational nursing skills essential for clinical practice.

Building on that foundation, accelerated NP programs are ideal for individuals looking to fast-track their nursing careers. These programs focus on nurse practitioner specialties, and exploring accelerated NP programs can help identify options suited to your goals in immunology and healthcare.

For nurse practitioners aiming to specialize further, bridging from an FNP to an acute care NP via a FNP to acute care NP bridge program offers a focused curriculum to handle complex patient cases, often linked to immunological conditions.

Understanding potential earnings is also crucial. Reviewing the doctor of nursing practice salary can provide insight into financial prospects across states for advanced practice nurses, helping you make informed career decisions alongside your studies in immunology.

Best Scientists Citing Douglas F. Nixon

Trending Scientists

Recently Published Articles